Business Wire
08 Jul 2026, 11:45 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Search tags
What the story claims
1 claim · each scored for market impact
The FDA has approved Johnson & Johnson's dual energy THERMOCOOL SMARTTOUCH SF platform. — FDA approvals for new medical platforms typically drive revenue growth and expand market share for the specific product line.
+0.30Which stocks this story touches
The company received FDA approval for its Dual Energy THERMOCOOL SMARTTOUCH SF Platform.
Continue reading
6 related stories
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
The Motley Fool
6h ago
